Skip to main navigation Skip to search Skip to main content

Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies

  • Lisa Pennells
  • , Stephen Kaptoge
  • , Angela Wood
  • , Mike Sweeting
  • , Xiaohui Zhao
  • , Ian White
  • , Stephen Burgess
  • , Peter Willeit
  • , Thomas Bolton
  • , Karel G. M. Moons
  • , Yvonne T. van der Schouw
  • , Randi Selmer
  • , Kay-Tee Khaw
  • , Vilmundur Gudnason
  • , Gerd Assmann
  • , Philippe Amouyel
  • , Veikko Salomaa
  • , Mika Kivimaki
  • , B. rge G. Nordestgaard
  • , Michael J. Blaha
  • Lewis H. Kuller, Hermann Brenner, Richard F. Gillum, Christa Meisinger, Ian Ford, Matthew W. Knuiman, Annika Rosengren, Debbie A. Lawlor, Henry Völzke, Cyrus Cooper, Alejandro Marín Ibañez, Edoardo Casiglia, Jussi Kauhanen, Jackie A. Cooper, Beatriz Rodriguez, Johan Sundström, Elizabeth Barrett-Connor, Rachel Dankner, Paul J. Nietert, Karina W. Davidson, Robert B. Wallace, Dan G. Blazer, Cecilia Björkelund, Chiara Donfrancesco, Harlan M. Krumholz, Aulikki Nissinen, Barry R. Davis, Sean Coady, Marjolein Visser, Jacqueline M. Dekker, Ron T. Gansevoort, Mark Woodward, Simon G. Thompson, John Danesh, Emanuele Angelantonio, Emerging Risk Factors Collaboration
  • University of Cambridge
  • University College London
  • Innsbruck Medical University
  • Utrecht University
  • Norwegian Institute of Public Health
  • Icelandic Heart Association
  • University of Iceland
  • Assmann Foundation for Prevention, Münster, Germany
  • Institut Pasteur de Lille
  • National Institute for Health and Welfare
  • University of Copenhagen
  • Johns Hopkins University
  • University of Pittsburgh
  • National Center for Tumor Diseases Heidelberg
  • University of Heidelberg, Heidelberg, Germany
  • Howard University
  • Helmholtz Zentrum München - German Research Center for Environmental Health
  • University of Glasgow
  • University of Western Australia
  • Sahlgrenska Academy
  • University of Gothenburg
  • University of Bristol
  • University of Greifswald
  • University of Southampton
  • San Jose Norte Health Centre, Spain
  • University of Padua
  • University of Eastern Finland
  • University of Hawai'i at Mānoa
  • Uppsala University
  • University of California at San Diego
  • The Gertner Institute
  • Tel Aviv University
  • Medical University of South Carolina
  • Columbia University
  • University of Iowa
  • Department of Surgery, Durham, United States
  • Istituto Superiore di Sanita
  • Yale University
  • University of Texas Health Science Center at Houston
  • National Institutes of Health
  • University of Groningen
  • University Medical Center Groningen
  • Medical Research Council
  • Wellcome Sanger Institute

Research output: Contribution to journalArticleAcademicpeer-review

51 Downloads (Pure)

Abstract

AIMS: There is debate about the optimum algorithm for cardiovascular disease (CVD) risk estimation. We conducted head-to-head comparisons of four algorithms recommended by primary prevention guidelines, before and after 'recalibration', a method that adapts risk algorithms to take account of differences in the risk characteristics of the populations being studied. METHODS AND RESULTS: Using individual-participant data on 360 737 participants without CVD at baseline in 86 prospective studies from 22 countries, we compared the Framingham risk score (FRS), Systematic COronary Risk Evaluation (SCORE), pooled cohort equations (PCE), and Reynolds risk score (RRS). We calculated measures of risk discrimination and calibration, and modelled clinical implications of initiating statin therapy in people judged to be at 'high' 10 year CVD risk. Original risk algorithms were recalibrated using the risk factor profile and CVD incidence of target populations. The four algorithms had similar risk discrimination. Before recalibration, FRS, SCORE, and PCE over-predicted CVD risk on average by 10%, 52%, and 41%, respectively, whereas RRS under-predicted by 10%. Original versions of algorithms classified 29-39% of individuals aged ≥40 years as high risk. By contrast, recalibration reduced this proportion to 22-24% for every algorithm. We estimated that to prevent one CVD event, it would be necessary to initiate statin therapy in 44-51 such individuals using original algorithms, in contrast to 37-39 individuals with recalibrated algorithms. CONCLUSION: Before recalibration, the clinical performance of four widely used CVD risk algorithms varied substantially. By contrast, simple recalibration nearly equalized their performance and improved modelled targeting of preventive action to clinical need.
Original languageEnglish
Pages (from-to)621-631
JournalEuropean heart journal
Volume40
Issue number7
DOIs
Publication statusPublished - 14 Feb 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies'. Together they form a unique fingerprint.

Cite this